Neuroendocrine Tumor Research Foundation
Elyse Gellerman serves as the Chief Executive Officer at Neuroendocrine Tumor Research Foundation. With a background in healthcare management and consulting, Elyse has held various executive positions in oncology services and business development at organizations such as HCA/Sarah Cannon Cancer Services and Aspen Healthcare Metrics. Elyse is skilled in strategic planning, clinical margin management, and market analysis, with a focus on driving growth and development in the healthcare industry. Elyse holds a MHS in Healthcare Systems and a Certificate in Healthcare Marketing from the University of Denver, as well as a BA in American History from Cornell University.
This person is not in any teams
Neuroendocrine Tumor Research Foundation
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for neuroendocrine cancer. To achieve rapid discovery of cures, the NET Research Foundation directs its donations to fund breakthrough scientific research of neuroendocrine cancers. Since its inception, the NET Research Foundation has awarded over $36 million in large-scale, multi-year research grants to leading scientists institutions around the world.